Xeris Pharmaceuticals
XERS
#6076
Rank
NZ$1.21 B
Marketcap
$7.88
Share price
-9.63%
Change (1 day)
131.68%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2024 (TTM): -NZ$43.01 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.20 Billion. , an increase over its 2023 earnings that were of -NZ$65.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$47.57 Million-27.85%
2023 -NZ$65.93 Million-54.31%
2022 -NZ$0.15 Billion-30.11%
2021 -NZ$0.21 Billion43.37%
2020 -NZ$0.15 Billion-32.21%
2019 -NZ$0.22 Billion106.61%
2018 -NZ$0.11 Billion116.69%
2017 -NZ$47.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion 436.82%๐Ÿ‡บ๐Ÿ‡ธ USA